RANI: Rani Therapeutics Holdings, Inc. Class A Common Stock Company Profile & Statistics

Rani Therapeutics Holdings, Inc. Class A Common Stock Profile

About

Rani Therapeutics Holdings Inc. is a clinical stage biotherapeutics company. It focused on advancing technologies to enable the development of orally administered biologics. Rani Therapeutics Holdings Inc. is based in SAN JOSE, Calif.

Info & Links

CEO

Talat Imran

Headquarters

2051 RINGWOOD AVENUE
SAN JOSE, CA 95131, UNITED STATES

Auditor

Marcum LLP

Share holders

138

Employees

106

Rani Therapeutics Holdings, Inc. Class A Common Stock Statistics

Valuation Measures

Market Capitalization²

24.76M

Enterprise Value

31.78M

Enterprise Value/EBITDA(ttm)

-0.64

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

Profit Margin(ttm)

-1055.81%

Return on Equity(ttm)

-1258.76%

Return on Invested Capital(ttm)

-2250.66%

Return on Assets(ttm)

-97.97%

Income Statement

Revenue(ttm)

172.00K

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

172.00K

EBITDA(ttm)³

-49.83M

Net Income Available to Common(ttm)

-29.69M

Diluted EPS(ttm)

-0.91

Share Statistics

Beta (5Y Monthly)

-0.02

52-Week Change

-78.42%

S&P 500 52-Week Change

17.90%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

71.87M

Dividend Yield

0.00%

Float⁴

39.47M

% Held by Insiders

45.08%

% Held by Institutions

30.19%

Balance Sheet

Total Cash(mrq)

10.22M

Total Cash Per Share(mrq)

0.14

Total Debt(mrq)

17.23M

Total Debt/Equity(mrq)

-188.23%

Current Ratio(mrq)

0.54%

Quick Ratio(mrq)

0.54%

Book Value Per Share(mrq)

-0.14

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.38

Free Cash Flow(ytd)

-14.03M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

RANI

Rani Therapeutics Holdings, Inc. Class A Common Stock